H.-M. Chang

1.2k total citations
24 papers, 828 citations indexed

About

H.-M. Chang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, H.-M. Chang has authored 24 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 7 papers in Oncology. Recurrent topics in H.-M. Chang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cerebrovascular and Carotid Artery Diseases (7 papers) and Gastric Cancer Management and Outcomes (5 papers). H.-M. Chang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cerebrovascular and Carotid Artery Diseases (7 papers) and Gastric Cancer Management and Outcomes (5 papers). H.-M. Chang collaborates with scholars based in South Korea, United States and United Kingdom. H.-M. Chang's co-authors include L. Dana DeWitt, Louis R. Caplan, Michael S. Pessin, Robert J. Wityk, Axel J. Rosengart, Ladislav Pazdera, L.R. Caplan, Hyun‐Il Shin, L R Caplan and M.-H. Ryu and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

H.-M. Chang

24 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.-M. Chang South Korea 15 497 304 290 210 135 24 828
Arvin R. Wali United States 17 204 0.4× 305 1.0× 236 0.8× 286 1.4× 49 0.4× 71 841
Sebastiano Fabiano Italy 18 374 0.8× 240 0.8× 229 0.8× 405 1.9× 41 0.3× 52 925
Shashvat M. Desai United States 24 700 1.4× 1.1k 3.5× 473 1.6× 167 0.8× 46 0.3× 94 1.5k
Eugene Lin United States 14 294 0.6× 291 1.0× 203 0.7× 142 0.7× 56 0.4× 27 677
Arturo Tamayo Canada 13 629 1.3× 432 1.4× 205 0.7× 94 0.4× 43 0.3× 27 897
Lucio Castellan Italy 14 230 0.5× 131 0.4× 260 0.9× 174 0.8× 25 0.2× 63 679
Matthew Matson United Kingdom 21 254 0.5× 127 0.4× 70 0.2× 575 2.7× 72 0.5× 52 1.1k
Christopher Doherty Canada 13 292 0.6× 131 0.4× 86 0.3× 276 1.3× 31 0.2× 41 679
Matthew Crocker United Kingdom 14 159 0.3× 109 0.4× 268 0.9× 253 1.2× 32 0.2× 53 731
Joseph Schmoker United States 17 298 0.6× 229 0.8× 555 1.9× 418 2.0× 52 0.4× 37 1.2k

Countries citing papers authored by H.-M. Chang

Since Specialization
Citations

This map shows the geographic impact of H.-M. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.-M. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.-M. Chang more than expected).

Fields of papers citing papers by H.-M. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.-M. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.-M. Chang. The network helps show where H.-M. Chang may publish in the future.

Co-authorship network of co-authors of H.-M. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of H.-M. Chang. A scholar is included among the top collaborators of H.-M. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.-M. Chang. H.-M. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wasan, Harpreet, James J. Harding, Jia Fan, et al.. (2023). 101P Quality of life (QoL) outcomes in patients (pts) with zanidatamab (zani)-treated HER2-positive (HER2+) biliary tract cancer (BTC) in the phase IIb HERIZON-BTC-01 study. Annals of Oncology. 34. S219–S219. 1 indexed citations
3.
Furuse, Junji, Lipika Goyal, Funda Meric‐Bernstam, et al.. (2020). 116MO Efficacy, safety, and quality of life (QoL) with futibatinib in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements: FOENIX-CCA2. Annals of Oncology. 31. S1288–S1289. 8 indexed citations
4.
Bridgewater, John, Funda Meric‐Bernstam, Antoine Hollebecque, et al.. (2020). 54P Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/other rearrangements: Subgroup analyses of a phase II study (FOENIX-CCA2). Annals of Oncology. 31. S261–S262. 14 indexed citations
5.
6.
Yoon, Dok Hyun, M.-H. Ryu, Heon‐Jin Lee, et al.. (2012). Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum. British Journal of Cancer. 106(6). 1039–1044. 70 indexed citations
7.
Silva, Deidre Anne De, H.-M. Chang, Christopher Chen, et al.. (2011). The relationship between aortic stiffness and changes in retinal microvessels among Asian ischemic stroke patients. Journal of Human Hypertension. 26(12). 716–722. 18 indexed citations
8.
Park, Hae‐Sim, Eun Young Choi, Sang Yeoup Lee, et al.. (2009). Gender and age differences in the impact of overweight on obesity-related quality of life among Korean adults. Obesity Research & Clinical Practice. 4(1). e15–e23. 24 indexed citations
9.
Han, Jee Hye, Hae‐Sim Park, Chol Shin, et al.. (2009). Metabolic syndrome and quality of life (QOL) using generalised and obesity-specific QOL scales. International Journal of Clinical Practice. 63(5). 735–741. 46 indexed citations
10.
Jo, Jae‐Cheol, J.-L. Lee, M.-H. Ryu, et al.. (2007). Docetaxel Monotherapy as a Second-line Treatment after Failure of Fluoropyrimidine and Platinum in Advanced Gastric Cancer: Experience of 154 Patients with Prognostic Factor Analysis. Japanese Journal of Clinical Oncology. 37(12). 936–941. 32 indexed citations
11.
Chang, H.-M., Hwey‐Lian Hsieh, Sheng‐Der Hsu, et al.. (2007). Guidewire assisted cephalic vein cutdown for insertion of totally implantable access ports. Journal of Surgical Oncology. 95(2). 156–157. 9 indexed citations
12.
Yu, Chang Sik, Min‐Hee Ryu, H.-M. Chang, et al.. (2006). Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. European Journal of Surgical Oncology. 32(9). 941–947. 57 indexed citations
13.
Chang, H.-M., et al.. (2005). An alternative technique for totally implantable central venous access devices. A retrospective study of 1311 cases. European Journal of Surgical Oncology. 32(1). 90–93. 43 indexed citations
14.
Caplan, L.R., et al.. (2005). New England Medical Center Posterior Circulation Stroke Registry II. Vascular Lesions. Journal of Clinical Neurology. 1(1). 31–31. 44 indexed citations
15.
Kang, Yubin, et al.. (2004). A phase I / II trial of docetaxel, capecitabine, and cisplatin as a first line chemotherapy for advanced gastric cancer. Journal of Clinical Oncology. 22(14_suppl). 4066–4066. 20 indexed citations
16.
17.
Shin, Hyun‐Il, et al.. (1999). Bilateral Intracranial Vertebral Artery Disease in the New England Medical Center Posterior Circulation Registry. Archives of Neurology. 56(11). 1353–1353. 51 indexed citations
18.
Chang, H.-M., et al.. (1998). Bilateral Anterior Inferior Cerebellar Artery Territory Infarcts. Journal of Neuroimaging. 8(1). 42–44. 1 indexed citations
19.
Martin, Peter J., et al.. (1998). Midbrain infarction: associations and aetiologies in the New England Medical Center Posterior Circulation Registry. Journal of Neurology Neurosurgery & Psychiatry. 64(3). 392–395. 41 indexed citations
20.
Wityk, Robert J., H.-M. Chang, Axel J. Rosengart, et al.. (1998). Proximal Extracranial Vertebral Artery Disease in the New England Medical Center Posterior Circulation Registry. Archives of Neurology. 55(4). 470–470. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arvin R. Wali Breakdown of academic impact, for papers by Sebastiano Fabiano Breakdown of academic impact, for papers by Shashvat M. Desai Breakdown of academic impact, for papers by Eugene Lin Breakdown of academic impact, for papers by Arturo Tamayo Breakdown of academic impact, for papers by Lucio Castellan Breakdown of academic impact, for papers by Matthew Matson Breakdown of academic impact, for papers by Christopher Doherty Breakdown of academic impact, for papers by Matthew Crocker Breakdown of academic impact, for papers by Joseph Schmoker
Rankless by CCL
2026